Altimmune ALT
NASDAQ ALT
$2.17 -0.06 (-2.69%)
At close: Oct 22, 2026 · 4:00 PM EDT

Altimmune (ALT) Amortization of Deferred Charges (2010 - 2026)

Updated

Analysis

Altimmune (ALT) Amortization of Deferred Charges (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Altimmune 391.03 Mn -751.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 237,000.00
Mar 31, 2026 218,000.00
Dec 31, 2025 192,000.00
Sep 30, 2025 113,000.00
Dec 31, 2018 60,587.00
Jun 30, 2017 59,790.00
Mar 31, 2017 38,270.00
Dec 31, 2010 1.91 Mn
Sep 30, 2010 934,655.00
API Access

Altimmune Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ALT&period=max&api_key=YOUR_API_KEY